The use of standardized extracts in allergen immunotherapy
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 106 (1) , 41-45
- https://doi.org/10.1067/mai.2000.107197
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-Term Clinical Efficacy of Grass-Pollen ImmunotherapyNew England Journal of Medicine, 1999
- Clinical efficacy of specific immunotherapy to cat dander: a double‐blind placebo‐controlled trialClinical and Experimental Allergy, 1997
- Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γJournal of Allergy and Clinical Immunology, 1996
- Booster immunotherapy (BIT)Allergy, 1994
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.The Journal of Experimental Medicine, 1993
- Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.BMJ, 1991
- Immunotherapy of hay fever with ragweed antigen E: Comparisons with whole pollen extract and placebosJournal of Allergy, 1968
- A Double-Blind Study of the Effectiveness and Specificity of Injection Therapy in Ragweed Hay FeverNew England Journal of Medicine, 1965